Cargando…

Gender-dependent miR-375 promoter methylation and the risk of type 2 diabetes

Promoter DNA methylation may reflect the interaction between genetic background and environmental factors in the development of metabolic disorders, including type 2 diabetes (T2D). As an epigenetic factor of T2D, miR-375 plays an important role in the functional accommodation of islet cells. In the...

Descripción completa

Detalles Bibliográficos
Autores principales:	CHENG, JIA, WANG, LINGYAN, XU, LEITING, WANG, HONGWEI, LIU, PANPAN, BU, SHIZHONG, YE, MENG, ZHANG, LINA, WANG, QINWEN, DUAN, SHIWEI
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2013
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702700/ https://www.ncbi.nlm.nih.gov/pubmed/23837055 http://dx.doi.org/10.3892/etm.2013.1069

Ejemplares similares

BCL11A gene DNA methylation contributes to the risk of type 2 diabetes in males
por: TANG, LINLIN, et al.
Publicado: (2014)

Investigation into the promoter DNA methylation of three genes (CAMK1D, CRY2 and CALM2) in the peripheral blood of patients with type 2 diabetes
por: CHENG, JIA, et al.
Publicado: (2014)

Genetic Associations with Diabetes: Meta-Analyses of 10 Candidate Polymorphisms
por: Tang, Linlin, et al.
Publicado: (2013)

Expression and prognostic significance of miR-375 and miR-221 in liver cancer
por: Xie, Dafei, et al.
Publicado: (2017)

MiR-375 attenuates injury of cerebral ischemia/reperfusion via targetting Ctgf
por: Ou, Jianying, et al.
Publicado: (2017)

miR-375 is upregulated in acquired paclitaxel resistance in cervical cancer
por: Shen, Y, et al.
Publicado: (2013)

Meta-analyses between 18 candidate genetic markers and overweight/obesity
por: Tang, Linlin, et al.
Publicado: (2014)

Exosome-Encapsulated miR-31, miR-192, and miR-375 Serve as Clinical Biomarkers of Gastric Cancer
por: He, Jing, et al.
Publicado: (2023)

Effects of lncRNA TUSC7 on the malignant biological behavior of osteosarcoma cells via regulation of miR-375
por: Wang, Lulu, et al.
Publicado: (2020)

The expression profiling of serum miR-92a, miR-134 and miR-375 in acute ischemic stroke
por: Salman, Aya Tarek, et al.
Publicado: (2023)

miR-148a and miR-375 may serve as predictive biomarkers for early diagnosis of laryngeal carcinoma
por: Wu, Ying, et al.
Publicado: (2016)

Evaluation of miR-21 and miR-375 as prognostic biomarkers in oesophageal cancer in high-risk areas in China
por: He, Yutong, et al.
Publicado: (2016)

Evaluation of serum miR‐216a and miR‐375 as biomarkers in dogs with acute pancreatitis
por: Lee, Dohee, et al.
Publicado: (2022)

miR-375 and miR-30d in the Effect of Chromium-Containing Chinese Medicine Moderating Glucose Metabolism
por: Zhang, Qian, et al.
Publicado: (2014)

MiR-375 and Doxorubicin Co-delivered by Liposomes for Combination Therapy of Hepatocellular Carcinoma
por: Fan, Yin-Ping, et al.
Publicado: (2017)

Elevated PLA2G7 Gene Promoter Methylation as a Gender-Specific Marker of Aging Increases the Risk of Coronary Heart Disease in Females
por: Jiang, Danjie, et al.
Publicado: (2013)

The Expression of miR-375 Is Associated with Carcinogenesis in Three Subtypes of Lung Cancer
por: Jin, Yi, et al.
Publicado: (2015)

Exosomes from LNCaP cells promote osteoblast activity through miR-375 transfer
por: Li, Su-Liang, et al.
Publicado: (2019)

Circulating Exosomal miR-141-3p and miR-375 in Metastatic Progression of Rectal Cancer
por: Meltzer, Sebastian, et al.
Publicado: (2019)

Combination of three miRNA (miR-141, miR-21, and miR-375) as potential diagnostic tool for prostate cancer recognition
por: Porzycki, Paweł, et al.
Publicado: (2018)

miR-21, miR-99b and miR-375 combination as predictive response signature for preoperative chemoradiotherapy in rectal cancer
por: Campayo, Marc, et al.
Publicado: (2018)

miR-145, miR-92a and miR-375 Show Differential Expression in Serum from Patients with Diabetic Retinopathies
por: Solis-Vivanco, Adriana, et al.
Publicado: (2022)

Transcriptional Mechanisms Controlling miR-375 Gene Expression in the Pancreas
por: Avnit-Sagi, Tali, et al.
Publicado: (2012)

Gold nanoparticles delivered miR-375 for treatment of hepatocellular carcinoma
por: Xue, Hui-Ying, et al.
Publicado: (2016)

MiR-375-3p Promotes Cardiac Fibrosis by Regulating the Ferroptosis Mediated by GPX4
por: Zhuang, Yu, et al.
Publicado: (2022)

miR-1269a and miR-1269b: Emerging Carcinogenic Genes of the miR-1269 Family
por: Xie, Zijun, et al.
Publicado: (2022)

miR-375 Mediated Acquired Chemo-Resistance in Cervical Cancer by Facilitating EMT
por: Shen, Yuanming, et al.
Publicado: (2014)

Aberrant miR-10b, miR-372, and miR-375 expression in the cytobrushed samples from oral potentially malignant disorders
por: Tu, Hsi-Feng, et al.
Publicado: (2022)

Upregulated expression of serum exosomal miR-375 and miR-1307 enhance the diagnostic power of CA125 for ovarian cancer
por: Su, Ying Ying, et al.
Publicado: (2019)

MiR-93/miR-375: Diagnostic Potential, Aggressiveness Correlation and Common Target Genes in Prostate Cancer
por: Ciszkowicz, Ewa, et al.
Publicado: (2020)

The Role of miR-375-3p and miR-200b-3p in Gastrointestinal Stromal Tumors
por: Gyvyte, Ugne, et al.
Publicado: (2020)

Circulating miR-92b and miR-375 for monitoring the chemoresistance and prognosis of small cell lung cancer
por: Li, Ming, et al.
Publicado: (2020)

Circulating miR-141 and miR-375 are associated with treatment outcome in metastatic castration resistant prostate cancer
por: Zedan, A. H., et al.
Publicado: (2020)

Low Expression of miR-375 and miR-190b Differentiates Grade 3 Patients with Endometrial Cancer
por: Pietrus, Miłosz, et al.
Publicado: (2021)

High miR203a-3p and miR-375 expression in the airways of smokers with and without COPD
por: van Nijnatten, Jos, et al.
Publicado: (2022)

MiR-375 and miR-21 as Potential Biomarkers of Prostate Cancer: Comparison of Matching Samples of Plasma and Exosomes
por: Joković, Suzana Matijašević, et al.
Publicado: (2022)

LUCAT1 as an oncogene in tongue squamous cell carcinoma by targeting miR‐375 expression
por: Zhang, Kai, et al.
Publicado: (2021)

miR-93/miR-106b/miR-375-CIC-CRABP1: a novel regulatory axis in prostate cancer progression
por: Choi, Nahyun, et al.
Publicado: (2015)

Serum miR-375 for Diagnostic and Prognostic Purposes in Medullary Thyroid Carcinoma
por: Censi, Simona, et al.
Publicado: (2021)

Dual regulation of miR-375 and CREM genes in pancreatic beta cells
por: Keller, David M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3adt0lb466jn6ki84teocj1tlg